Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
04/24/2003 | WO2003033461A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
04/24/2003 | WO2003033447A1 Luminous compounds and labeling reagents using the same |
04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/24/2003 | US20030078444 Fluorous triphase and ther multiphase systems for effecting reactions and/or separation |
04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
04/24/2003 | US20030078437 Novel benzamidoxime derivatives, intermediates and process for their preparation, and their use as fungicides |
04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
04/24/2003 | US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
04/24/2003 | US20030078422 Tetrahydrobenzofuran or tetrahydrobenzothiophen or tetrahdyrobenzopyrrole compounds can be aromatized with a hydrogenation catalyst in presence of a hydrogen acceptor, deacylation of amino group by addition of an amine group |
04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
04/24/2003 | US20030078418 Useful potentiators of beta -lactam antibiotics; therapy |
04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
04/24/2003 | US20030078287 For controlling plant and animal pests |
04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
04/24/2003 | US20030078264 Treating atherosclerosis and other coronary artery diseases |
04/24/2003 | US20030078261 Prostaglandin agonists |
04/24/2003 | US20030078248 Treating ischemic disease, cardiac arrhythmias, chronic pain, inducing sleep in a mammal |
04/24/2003 | US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
04/24/2003 | CA2464435A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
04/23/2003 | EP1303503A2 Aniline derivatives |
04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
04/23/2003 | EP0993442B1 Hydrazine derivatives |
04/23/2003 | EP0981524B1 New intermediates and process for the preparation thereof |
04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
04/23/2003 | EP0865423B1 Iminoacetic acid amides and their use as pest control agents |
04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
04/22/2003 | US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
04/22/2003 | US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
04/17/2003 | WO2003032072A2 Crosslinkable monomers for novel nonlinear optical polymers |
04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
04/17/2003 | WO2002092564A3 Synthesis of cyclopentadiene derivatives |
04/17/2003 | WO2002081735A3 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
04/17/2003 | WO2001092251A3 Aryloxy ester and acid compounds |
04/17/2003 | WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
04/17/2003 | US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
04/17/2003 | US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
04/17/2003 | US20030073733 Pharmaceutically active compounds and methods of use |
04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
04/17/2003 | US20030073709 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
04/17/2003 | US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient |
04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
04/17/2003 | US20030070240 N-heteroarylmethyl-p-phnylendiamine derivatives and compounds containing oxidationcoloring agents |
04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
04/16/2003 | EP1301505A2 Thiophene retinoids |
04/16/2003 | EP1301502A1 Novel compounds and their use as glycine transport inhibitors |
04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
04/16/2003 | EP1301475A1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
04/16/2003 | EP0925529B1 Alkysulfonyloximes for high-resolution i-line photoresists of high sensitivity |
04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
04/16/2003 | CN1105718C Improved method for producing thiazolidinediones, and new thiazolidinediones |
04/16/2003 | CN1105717C Substituted sulphonylamino (thio) carbony/compounds |
04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
04/15/2003 | US6548549 Fungicides, insecticides, bactericides; applying to plant |
04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
04/15/2003 | US6548546 HIV integrase inhibitors |
04/15/2003 | US6548538 Potent peroxisome proliferator activated receptor (PPAR)-alpha-activating compounds; propionic acid 2-subsituted with an N-(phenylaminocarbonylalkyl), N-(2-furanylmethyl)aminoalkylphenyl group |
04/15/2003 | US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms |
04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
04/15/2003 | US6548220 Containing acid generator |
04/15/2003 | CA2097715C Indan derivatives |
04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
04/10/2003 | WO2003029241A1 Chk1 kinase inhibitors |
04/10/2003 | WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists |
04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
04/10/2003 | WO2003029188A2 Beta-substituted nitrostyrene and cyanostyrene compounds and their use as nematicides and fungicides |
04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
04/10/2003 | WO2003028641A2 Mch receptor antagonists |
04/10/2003 | WO2003007069A3 Novel nonlinear optical polymers |
04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |